AMERIPRISE FINANCIAL INC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$527,165
-70.4%
63,058
-12.1%
0.00%
-100.0%
Q2 2023$1,782,593
+64.9%
71,763
-0.1%
0.00%
Q1 2023$1,080,819
+432.4%
71,863
+1277.5%
0.00%
Q2 2021$203,000
-1.5%
5,217
+32.0%
0.00%
Q4 2020$206,000
-32.2%
3,951
-87.2%
0.00%
Q1 2020$304,000
+82.0%
30,905
+105.2%
0.00%
Q4 2019$167,000
-78.7%
15,058
-84.3%
0.00%
Q4 2017$785,000
-63.3%
95,704
-47.0%
0.00%
-100.0%
Q3 2017$2,140,000
-23.2%
180,651
-34.8%
0.00%0.0%
Q2 2017$2,786,000
+115.8%
277,235
+150.2%
0.00%0.0%
Q1 2017$1,291,000
-20.0%
110,801
+13.9%
0.00%0.0%
Q2 2015$1,614,000
+44.6%
97,285
+35.0%
0.00%0.0%
Q1 2015$1,116,000
-29.2%
72,069
-27.5%
0.00%0.0%
Q4 2014$1,576,000
+57.1%
99,464
+5.8%
0.00%0.0%
Q3 2014$1,003,00093,975
+469775.0%
0.00%
Q2 2014$0
-100.0%
20
-97.9%
0.00%
Q3 2013$5,0000.0%967
+21.5%
0.00%
Q2 2013$5,0007960.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders